2013 InterLymph Meeting

Members of the International Lymphoma Epidemiology Consortium (InterLymph) and other interested individuals were invited to attend the 2013 Annual Meeting at the Faculty of Medicine, University of Dijon in France. The meeting was held June 24-26, 2013.


Agenda

View agenda for Monday June 24
Monday June 24 Topic
9:00 a.m. Registration
9:45 a.m. Welcome (M Maynadié)
10:00 a.m. - 11:30 a.m. Latest findings from the InterLymph Consortium (Chairs: S Wang, X Troussard)
10:00 a.m. - 10:20 a.m. Comparison of risk factors for all subtypes (L Morton)
10:20 a.m. - 10:40 a.m. Key risk factors for rarer B-cell subtypes (A Monnereau/P Bracci)
10:40 a.m. - 11:00 a.m. Genome-wide association study (GWAS) of non-Hodgkin lymphoma subtypes: an overview (N Rothman)
11:00 a.m. - 11:20 a.m. Interaction between autoimmune disease and immune polymorphisms in risk of non-Hodgkin lymphoma (S Wang)
11:20 a.m. - 11:30 a.m. Discussion
11:30 a.m. - 12:00 p.m. Coffee break / Morning tea / Poster session
12:00 p.m. - 1:30 p.m. Lymphoma and Survival (Chairs: K Ekstrom-Smedby, T Lamy)
12:00 p.m. - 12:20 p.m. Survival of lymphoma in Europe (M Sant)
12:20 p.m. - 12:40 p.m. Lifestyle factors and non-Hodgkin lymphoma survival (A Seniori)
12:40 p.m. - 1:00 p.m. Prognostic Factors in Lymphoma: Can observational epidemiology studies get the same answers as RCTs? (J Cerhan)
1:00 p.m. - 1:20 p.m. Germline genetic variation and lymphoma outcomes (H Ghesquieres)
1:20 p.m. - 1:30 p.m. Discussion
1:30 p.m. - 2:20 p.m. Lunch
2:20 p.m. - 3:00 p.m. Hodgkin Lymphoma (Chairs: S Slager, RO Casasnovas)
2:20 p.m. - 2:40 p.m. Risk factors for Classical Hodgkin lymphoma (H Hjalgrim)
2:40 p.m. - 3:00 p.m. Meta analysis of the GWAS strategy in Hodgkin lymphoma (W Cozen)
3:00 p.m. - 3:20 p.m. Defining a Predictive Blood Biomarker for Follicular Lymphoma (B Nadel)
3:20 p.m. - 3:30 p.m. Discussion
3:30 p.m. - 4:00 p.m. Coffee break / Afternoon tea / Poster session
4:00 p.m. - 5:30 p.m. Round table: Second cancer in lymphoid malignancies (Chairs: L Morton, G Salles)
4:00 p.m. - 4:20 p.m. K2-France Project (J Jégu)
4:20 p.m. - 4:40 p.m. K2-France: second cancer in Follicular Lymphoma and in DLBCL (C Rossi)
4:40 p.m. - 5:00 p.m. Second cancer in Follicular Lymphoma included in clinical trials (C Thieblemont)
5:00 p.m. - 5:20 p.m. K2-France: second cancer in CLL (X Troussard)
5:20 p.m. - 5:30 p.m. Discussion
5:30 p.m. Wrap-up (M Maynadié)

View agenda for Tuesday, June 24
Tuesday, June 24 Topic
7:30 a.m. - 8:00 a.m. On-site Registration
8:00 a.m. - 10:00 a.m. Pathology /Survival working group meeting
Subtypes Initiative
10:00 a.m. - 10:30 a.m. Coffee break / Morning tea
10:30 a.m. - 12:30 p.m. Immunology and Infection working group
12:30 p.m. - 2:00 p.m. Working Lunch
INTERLYMPH Business meeting
Group photo
2:00 p.m. - 4:00 p.m. Lifestyle and Environment working group
4:00 p.m. - 4:30 p.m. Coffee break / Afternoon tea
4:30 p.m. - 6:30 p.m. GWAS Initiative
6:30 p.m. Dinner

View agenda for Wednesday, June 26
Wednesday, June 26 Topic
8:00 a.m. - 9:40 a.m. Hodgkin Lymphoma Working Group
9:40 a.m. - 10:00 a.m. Coffee break / Morning tea
10:00 a.m. - 12:00 p.m Hodgkin Lymphoma Working Group
12:00 p.m. - 1:00 p.m. Lunch
1:00 p.m. - 2:00 p.m. Family studies working group
2:00 p.m. - 3:00 p.m. International Multiple Myeloma Consortium
3:00 p.m. - 3:20 p.m. Coffee break / Afternoon tea
3:20 p.m. - 6:00 p.m. International Multiple Myeloma Consortium

Return to Top

Scientific Committee Members

  • Olivier Casasnovas, M.D.
    Centre Hospitalier Universitaire Dijon
  • Cindy Chang, Ph.D.
    Food and Drug Administration
  • Brian Chiu, Ph.D.
    University of Chicago
  • Alain Delmer, M.D.
    CHU de Reims
  • Karin Ekstrom Smedby, Ph.D.
    Karolinska Institute
  • Philippe Gaulard, M.D.
    Hospital Henri Mondor
  • Thierry Lamy de la Chapelle, Ph.D.
    Université de Rennes
  • Véronique Leblond, M.D.
    Département d' Hématologie Hôpital Pitié-Salpêtrière APHP
  • Steven Le Gouill, Ph.D.
    CHU de Nantes
  • Marc Maynadié, M.D., Ph.D.
    Université de Bourgogne
  • Alain Monnereau, M.D., Ph.D.
    Institut Bergonié
  • Lindsay Morton, Ph.D.
    National Cancer Institute
  • Nat Rothman, M.D.
    National Cancer Institute
  • Gilles Salles, M.D., Ph.D.
    Université de Lyon
  • Susan Slager, Ph.D.
    Mayo Clinic
  • Xavier Troussard, Ph.D.
    Registre des H'emopathies Malignes de Basse Normandie
  • Claire Vajdic, Ph.D.
    University of New South Wales
  • Anke van den Berg, Ph.D.
    University of Groningen
  • Sophia Wang, Ph.D.
    City of Hope

Return to Top

Sponsors

  • Lymphoma Coalition
  • Faculté de Médecine de Dijon
  • Institut de Veille Sanitaire
  • Registre des hémopathies malignes de Côte d'Or
  • INSERM
  • Institut National du Cancer
  • Université de Bourgogne
  • Groupe Ouest Est d'Etude des Leucémies et Autres Maladies du Sang (GOELAMS)
  • l'Institut Bergonié
  • The Lymphoma Study Association (LYSA)
  • Registre Régional des Hémopathies de Basse Normandie
  • City of Dijon, France

Return to Top